Warren Buffett’s investment philosophy emphasizes caution in times of market exuberance and a readiness to buy when fear prevails. Currently, shares of Centessa Pharmaceuticals PLC (CNTA) are exhibiting this fear, with a Relative Strength Index (RSI) of 28.4, indicating an oversold condition following a low trading price of $22.44 per share on Monday. In contrast, the S&P 500 ETF (SPY) shows a healthier RSI of 60.5.
Centessa Pharmaceuticals’ recent trading results reflect a significant 52-week range, with a low of $9.60 and a high of $30.58, compared to their latest price of $22.51.
